Bioenergetic origins of complexity and disease

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 76, Issue , 2011, Pages 1-16

  Wallace, D C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A; CARBON; CELL NUCLEUS DNA; HYDROGEN; MITOCHONDRIAL DNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PYRUVIC ACID DERIVATIVE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; UBIDECARENONE; NUCLEIC ACID;

AGING; ARTICLE; BIOENERGY; CELL DEATH; CELL DIVISION; DNA REPLICATION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRIAL GENETICS; MITOCHONDRIAL GENOME; NEOPLASM; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOMATIC MUTATION; SYMBIOSIS; UPREGULATION; ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; BACTERIAL GENOME; DIABETES MELLITUS; DNA MUTATIONAL ANALYSIS; GENETIC VARIATION; MALIGNANT NEOPLASM; MITOCHONDRION; OBESITY; PARKINSON DISEASE; SOMATIC CELL;

AGING; ANIMALS; CELLULAR MICROENVIRONMENT; DISEASE; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; MUTATION;

EID: 84867417361     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2011.76.010462     Document Type: Article

References (139)

1. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, et al. 2000. The common PPARg Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26: 76-80.
2. Alzheimer's Association, ThiesW, Bleiler L. 2011. Alzheimer's Association report: 2011 Alzheimer's disease facts and figures. Alzheimer's Dement 7: 208-244.
3. Antonicka H, Ostergaard E, Sasarman F, Weraarpachai W, Wibrand F, Pedersen AM, Rodenburg RJ, van der Knaap MS, Smeitink JA, Chrzanowska-Lightowlers ZM, et al. 2010. Mutations in C12orf65 in patients with encephalomyopathy and a mitochondrial translation defect. Am J Hum Genet 87: 115-122.
4. Baracca A, Solaini G, Sgarbi G, Lenaz G, Baruzzi A, Schapira AH, Martinuzzi A, Carelli V. 2005. Severe impairment of complex I-driven adenosine triphosphate synthesis in Leber hereditary optic neuropathy cybrids. Arch Neurol 62: 730-736.
5. Baughman JM, Perocchi F, Girgis HS, Plovanich M, Belcher-Timme CA, Sancak Y, Bao XR, Strittmatter L, Goldberger O, Bogorad RL, et al. 2011. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476: 341-345.
6. Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, et al. 2006. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38: 515-517.
7. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 3: 1301-1306.
8. Bogenhagen DF, Rousseau D, Burke S. 2008. The layered structure of human mitochondrial DNA nucleoids. J Biol Chem 283: 3665-3675.
9. Borland MK, Mohanakumar KP, Rubinstein JD, Keeney PM, Xie J, Capaldi R, Dunham LD, Trimmer PA, Bennett JP Jr. 2009. Relationships among molecular genetic and respiratory properties of Parkinson's disease cybrid cells show similarities to Parkinson's brain tissues. Biochim Biophys Acta 1792: 68-74.
10. Brandt U. 2011. A two-state stabilization-change mechanism for proton-pumping complex I. Biochim Biophys Acta 1807: 1364-1369.
11. Brown MD, Torroni A, Reckord CL, Wallace DC. 1995. Phylogenetic analysis of Leber's hereditary optic neuropathy mitochondrial DNA's indicates multiple independent occurrences of the common mutations. Hum Mutat 6: 311-325.
12. Brown MD, Sun F, Wallace DC. 1997. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet 60: 381-387.
13. Brown MD, Trounce IA, Jun AS, Allen JC, Wallace DC. 2000. Functional analysis of lymphoblast and cybrid mitochondria containing the 3460, 11778, or 14484 Leber's Hereditary Optic Neuropathy mtDNA mutation. J Biol Chem 275: 39831-39836.
14. Brown MD, Allen JC, Van Stavern GP, Newman NJ, Wallace DC. 2001. Clinical, genetic, and biochemical characterization of a Leber Hereditary Optic Neuropathy family containing both the 11778 and 14484 primary mutations. Am J Med Genet 104: 331-338.
15. Brown MD, Starikovskaya E, Derbeneva O, Hosseini S, Allen JC, Mikhailovskaya IE, Sukernik RI, Wallace DC. 2002. The role of mtDNA background in disease expression: A new primary LHON mutation associated with Western Eurasian haplogroup J. Hum Genet 110: 130-138.
16. Burbulla LF, Krebiehl G, Kruger R. 2010. Balance is the challenge- The impact of mitochondrial dynamics in Parkinson's disease. Eur J Clin Invest 40: 1048-1060.
17. Cann RL, Stoneking M, Wilson AC. 1987. Mitochondrial DNA and human evolution. Nature 325: 31-36.
18. Cannon JR, Greenamyre JT. 2010. Neurotoxic in vivo models of Parkinson's disease recent advances. Prog Brain Res 184: 17-33.
19. CarelliV, Ghelli A, Ratta M, Bacchilega E, Sangiorgi S, Mancini R, Leuzzi V, Cortelli P, Montagna P, Lugaresi E, et al. 1997. Leber's hereditary optic neuropathy: Biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype. Neurology 48: 1623-1632.
20. Carelli V, Ghelli A, Bucchi L, Montagna P, De Negri A, Leuzzi V, Carducci C, Lenaz G, Lugaresi E, Degli Esposti M. 1999. Biochemical features of mtDNA 14484 (ND6/M64V) point mutation associated with Leber's hereditary optic neuropathy. Ann Neurol 45: 320-328.
21. Carrieri G, Bonafe M, De Luca M, Rose G, Varcasia O, Bruni A, Maletta R, Nacmias B, Sorbi S, Corsonello F, et al. 2001. Mitochondrial DNA haplogroups and APOE4 allele are nonindependent variables in sporadic Alzheimer's disease. Hum Genet 108: 194-198.
22. Chagnon P, Gee M, Filion M, Robitaille Y, Belouchi M, Gauvreau D. 1999. Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am J Med Genet 85: 20-30.
23. Chan NC, Salazar AM, Pham AH, Sweredoski MJ, Kolawa NJ, Graham RL, Hess S, Chan DC. 2011. Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy. Hum Mol Genet 20: 1726-1737.
24. Chen H, Chan DC. 2005. Emerging functions of mammalian mitochondrial fusion and fission. Hum Mol Genet 14 (suppl 2): R283-R289.
25. Chen H, Chan DC. 2009. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet 18: R169-R176.
26. Chen YS, Torroni A, Excoffier L, Santachiara-Benerecetti AS, Wallace DC. 1995. Analysis of mtDNA variation in African populations reveals the most ancient of all human continentspecific haplogroups. Am J Hum Genet 57: 133-149.
27. Chen H, Vermulst M, Wang YE, Chomyn A, Prolla TA, McCaffery JM, Chan DC. 2010. Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations. Cell 141: 280-289.
28. Copeland WC. 2010. The mitochondrial DNA polymerase in health and disease. Subcell Biochem 50: 211-222.
29. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC. 1992. Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age. Nat Genet 2: 324-329.
30. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, McKee AC, Beal MF, Graham BH, Wallace DC. 1994. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics 23: 471-476.
31. Cortopassi GA, Shibata D, Soong NW, Arnheim N. 1992. A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci 89: 7370-7374.
32. Coskun PE, Ruiz-Pesini EE, Wallace DC. 2003. Control region mtDNA variants: Longevity, climatic adaptation and a forensic conundrum. Proc Natl Acad Sci 100: 2174-2176.
33. Coskun PE, Beal MF, Wallace DC. 2004. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci 101: 10726-10731.
34. Coskun PE, Wyrembak J, Derbereva O, Melkonian G, Doran E, Lott IT, Head E, Cotman CW, Wallace DC. 2010. Systemic mitochondrial dysfunction and the etiology of Alzheimer's disease and down syndrome dementia. J Alzheimer's Dis 20 (suppl. 2): S293-S310.
35. Coskun P, Wyrembak J, Schriner S, Chen HW, Marciniack C, LaFerla F, Wallace DC. 2011. A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim Biophys Acta doi: 10.1016/j.bbagen.2011.08.008.
36. Dalgaard LT. 2011. Genetic variance in uncoupling protein 2 in relation to obesity, type 2 diabetes, and related metabolic traits: Focus on the functional -866G.A promoter variant (rs659366). J Obes 2011: 1-12.
37. Denaro M, Blanc H, Johnson MJ, Chen KH, Wilmsen E, Cavalli Sforza LL, Wallace DC. 1981. Ethnic variation in Hpa 1 endonuclease cleavage patterns of human mitochondrial DNA. Proc Natl Acad Sci 78: 5768-5772.
38. Deshpande A, Mina E, Glabe C, Busciglio J. 2006. Different conformations of amyloid b induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26: 6011-6018.
39. De Stefani D, Raffaello A, Teardo E, Szabo I, Rizzuto R. 2011. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476: 336-340.
40. Efremov RG, Sazanov LA. 2011. Structure of the membrane domain of respiratory complex I. Nature 476: 414-420.
41. Efremov RG, Baradaran R, Sazanov LA. 2010. The architecture of respiratory complex I. Nature 465: 441-445.
42. Ek J, Andersen G, Urhammer SA, Gaede PH, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O. 2001. Mutation analysis of peroxisome proliferator-activated receptor-g coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Diabetologia 44: 2220-2226.
43. Fan W, Waymire K, Narula N, Li P, Rocher C, Coskun PE, Vannan MA, Narula J, MacGregor GR, Wallace DC. 2008. A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science 319: 958-962.
44. Fratter C, Gorman GS, Stewart JD, Buddles M, Smith C, Evans J, Seller A, Poulton J, Roberts M, Hanna MG, et al. 2010. The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. Neurology 74: 1619-1626.
45. Gegg ME, Schapira AH. 2011. PINK1-parkin-dependent mitophagy involves ubiquitination of mitofusins 1 and 2: Implications for Parkinson disease pathogenesis. Autophagy 7: 243-245.
46. Gilkerson RW. 2009. Mitochondrial DNA nucleoids determine mitochondrial genetics and dysfunction. Int J Biochem Cell Biol 41: 1899-1906.
47. Glabe CG, Kayed R. 2006. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66: S74-S78.
48. Gomez-Duran A, Pacheu-Grau D, Lopez-Gallardo E, Diez-Sanchez C, Montoya J, Lopez-Perez MJ, Ruiz-Pesini E. 2010. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups. Hum Mol Genet 19: 3343-3353.
49. Goto Y, Nonaka I, Horai S. 1990. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348: 651-653.
50. Graef M, Nunnari J. 2011a. Mitochondria regulate autophagy by conserved signalling pathways. EMBO J 30: 2101-2114.
51. Graef M, Nunnari J. 2011b. A role for mitochondria in autophagy regulation. Autophagy 7: 1245-1246.
52. Greggio E, Bisaglia M, Civiero L, Bubacco L. 2011. Leucinerich repeat kinase 2 and a-synuclein: Intersecting pathways in the pathogenesis of Parkinson's disease? Mol Neurodegener 6: 6.
53. Guo M. 2010. What have we learned from Drosophila models of Parkinson's disease? Prog Brain Res 184: 3-16.
54. Guzman JN, Sanchez-Padilla J, Wokosin D, Kondapalli J, Ilijic E, Schumacker PT, Surmeier DJ. 2010. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468: 696-700.
55. Holt IJ, Harding AE, Morgan-Hughes JA. 1988. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331: 717-719.
56. Huoponen K, Vilkki J, Aula P, Nikoskelainen EK, Savontaus ML. 1991. A new mtDNA mutation associated with Leber hereditary optic neuroretinopathy. Am J Hum Genet 48: 1147-1153.
57. Hutchin T, Cortopassi G. 1995. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci 92: 6892-6895.
58. Inoue K, Nakada K, Ogura A, Isobe K, Goto Y, Nonaka I, Hayashi J-I. 2000. Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nat Genet 26: 176-181.
59. Iwata S, Lee JW, Okada K, Lee JK, Iwata M, Rasmussen B, Link TA, Ramaswamy S, Jap BK. 1998. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science 281: 64-71.
60. Jia JJ, Tian YB, Cao ZH, Tao LL, Zhang X, Gao SZ, Ge CR, Lin QY, Jois M. 2010. The polymorphisms of UCP1 genes associated with fat metabolism, obesity and diabetes. Mol Biol Rep 37: 1513-1522.
61. Johns DR, Neufeld MJ, Park RD. 1992. An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy. Biochem Biophys Res Commun 187: 1551-1557.
62. Johnson MJ, Wallace DC, Ferris SD, Rattazzi MC, Cavalli-Sforza LL. 1983. Radiation of human mitochondria DNA types analyzed by restriction endonuclease cleavage patterns. J Mol Evol 19: 255-271.
63. Jun AS, Brown MD, Wallace DC. 1994. A mitochondrial DNA mutation at np 14459 of the ND6 gene associated with maternally inherited Leber's hereditary optic neuropathy and dystonia. Proc Natl Acad Sci 91: 6206-6210.
64. Jun AS, Trounce IA, Brown MD, Shoffner JM, Wallace DC. 1996. Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia. Mol Cell Biol 16: 771-777.
65. Jun HS, Kim IK, Lee HJ, Lee HJ, Kang JH, Kim JR, Shin HD, Song J. 2009. Effects of UCP2 and UCP3 variants on the manifestation of overweight in Korean children. Obesity 17: 355-362.
66. Kamp F, Exner N, Lutz AK, Wender N, Hegermann J, Brunner B, Nuscher B, Bartels T, Giese A, Beyer K, et al. 2010. Inhibition of mitochondrial fusion by a-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J 29: 3571-3589.
67. Kazuno AA, Munakata K, Nagai T, Shimozono S, Tanaka M, Yoneda M, Kato N, Miyawaki A, Kato T. 2006. Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet 2: e128.
68. Keeney PM, Dunham LD, Quigley CK, Morton SL, Bergquist KE, Bennett JP Jr. 2009. Cybrid models of Parkinson's disease show variable mitochondrial biogenesis and genotype- respiration relationships. Exp Neurol 220: 374-382.
69. Khusnutdinova E, Gilyazova I, Ruiz-Pesini E, Derbeneva O, Khusainova R, Khidiyatova I, Magzhanov R, Wallace DC. 2008.Amitochondrial etiology of neurodegenerative diseases: Evidence from Parkinson's disease. Ann NY Acad Sci 1147: 1-20.
70. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. 2006. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 38: 518-520.
71. Krebiehl G, Ruckerbauer S, Burbulla LF, Kieper N, Maurer B, Waak J, Wolburg H, Gizatullina Z, Gellerich FN, Woitalla D, et al. 2010. Reduced basal autophagy and impaired mitochondrial dynamics due to loss of Parkinson's disease-associated protein DJ-1. PLoS One 5: e9367.
72. Kuhn TS. 1996. The structure of scientific revolutions. University of Chicago Press, Chicago, IL.
73. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, Hofer T, Seo AY, Sullivan R, Jobling WA, et al. 2005. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309: 481-484.
74. Lakatos A, Derbeneva O, Younes D, Keator D, Bakken T, Lvova M, Brandon M, Guffanti G, Reglodi D, Saykin A, et al. 2010. Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiol Aging 31: 1355-1363.
75. Lane N, MartinW. 2010. The energetics of genome complexity. Nature 467: 929-934.
76. Langston JW, Ballard P, Tetrud JW, Irwin I. 1983. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979-980.
77. Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A, Anbinder Y, Berkowitz D, Hartman C, Barak M, et al. 2001. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29: 337-341.
78. McCoy MK, Cookson MR. 2011. DJ-1 regulation of mitochondrial function and autophagy through oxidative stress. Autophagy 7: 531-532.
79. MerriwetherDA, Clark AG, Ballinger SW, Schurr TG, SoodyallH, JenkinsT, Sherry ST, Wallace DC. 1991.The structure of human mitochondrial DNAvariation. J Mol Evol 33: 543-555.
80. Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. 1999. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286: 774-779.
81. Mishmar D, Ruiz-Pesini EE, Golik P, Macaulay V, Clark AG, Hosseini S, Brandon M, Easley K, Chen E, Brown MD, et al. 2003. Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci 100: 171-176.
82. Montiel-Sosa F, Ruiz-Pesini E, Enriquez JA, Marcuello A, Diez-Sanchez C, Montoya J, Wallace DC, Lopez-Perez MJ. 2006. Differences of sperm motility in mitochondrial DNA haplogroup U sublineages. Gene 368C: 21-27.
83. Morowitz HJ. 1968. Energy flow in biology, biological organization as a problem in thermal physics. Academic Press, New York.
84. Muller YL, Bogardus C, Pedersen O, Baier L. 2003.AGly482Ser missense mutation in the peroxisome proliferator-activated receptor g coactivator-1 is associated with altered lipid oxidation and early insulin secretion in Pima Indians. Diabetes 52: 895-898.
85. Murdock DG, Christacos NC, Wallace DC. 2000. The agerelated accumulation of a mitochondrial DNA control region mutation in muscle, but not brain, detected by a sensitive PNA-directed PCR clamping based method. Nucl Acids Res 28: 4350-4355.
86. Narendra D, Tanaka A, Suen DF, Youle RJ. 2008. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183: 795-803.
87. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, Youle RJ. 2010. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8: e1000298.
88. Nishino I, Spinazzola A, Hirano M. 1999. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283: 689-692.
89. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM. 2003. Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Ab and synaptic dysfunction. Neuron 39: 409-421.
90. Pagliarini DJ, Calvo SE, Chang B, Sheth SA, Vafai SB, Ong SE, Walford GA, Sugiana C, Boneh A, Chen WK, et al. 2008. A mitochondrial protein compendium elucidates complex I disease biology. Cell 134: 112-123.
91. Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro A, Lupoli S, Salvi E, et al. 2009. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One 4: e6501.
92. Poulton J, MortenKJ, Marchington D, WeberK, BrownGK, Rotig A, Bindoff L. 1995. Duplications of mitochondrial DNA in Kearns-Sayre syndrome. Muscle Nerve 3: S154-S158.
93. Prachar J. 2010. Mouse and human mitochondrial nucleoid- Detailed structure in relation to function. Gen Physiol Biophys 29: 160-174.
94. Ricardo A, Szostak JW. 2009. Origin of life on earth. Sci Am 301: 54-61.
95. Roses AD. 2009. The medical and economic roles of pipeline pharmacogenetics: Alzheimer's disease as a model of efficacy and HLA-B(*)5701 as a model of safety. Neuropsychopharmacology 34: 6-17.
96. Ruiz-Pesini E, Wallace DC. 2006. Evidence for adaptive selection acting on the tRNA and rRNA genes of the human mitochondrial DNA. Hum Mutat 27: 1072-1081.
97. Ruiz-Pesini E, Lapena AC, Diez-Sanchez C, Perez-Martos A, Montoya J, Alvarez E, Diaz M, Urries A, Montoro L, Lopez-Perez MJ, et al. 2000. Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am J Hum Genet 67: 682-696.
98. Ruiz-Pesini E, Mishmar D, Brandon M, Procaccio V, Wallace DC. 2004. Effects of purifying and adaptive selection on regional variation in human mtDNA. Science 303: 223-226.
99. Ruiz-Pesini E, Lott MT, Procaccio V, Poole J, Brandon MC, Mishmar D, Yi C, Kreuziger J, Baldi P, Wallace DC. 2007. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucl Acids Res 35: D823-D828.
100. Santoro A, Balbi V, Balducci E, Pirazzini C, Rosini F, Tavano F, Achilli A, Siviero P, Minicuci N, BellavistaE, et al. 2010.Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease. PLoS One 5: e12037.
101. Saraste M. 1999. Oxidative phosphorylation at the fin de siecle. Science 283: 1488-1493.
102. Schon EA, Gilkerson RW. 2010. Functional complementation of mitochondrial DNAs: Mobilizing mitochondrial genetics against dysfunction. Biochim Biophys Acta 1800: 245-249.
103. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, Coskun PE, Ladiges W, Wolf N, Van Remmen H, et al. 2005. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 308: 1909-1911.
104. Schurr TG, Donham BP, Morreale SC, Panter-Brick C, Donham DL, Armelagos GJ, Wallace DC. 2005. Genetic diversity in modern African populations and its use for reconstructing ancient and modern population movements. In Biomolecular archeology, genetic approaches to the past (ed. Reed DM), occasional paper no. 31, 169-207. Center for Archaeological Investigations, Southern Illinois University, Carbondale, IL.
105. Shoffner JM, Lott MT, Lezza AM, Seibel P, Ballinger SW, Wallace DC. 1990. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 61: 931-937.
106. Shoffner JM, Brown MD, Torroni A, LottMT, Cabell MR, Mirra SS, Beal MF, Yang C, Gearing M, Salvo R, et al. 1993. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17: 171-184.
107. Smeitink JA, Elpeleg O, Antonicka H, Diepstra H, Saada A, Smits P, Sasarman F, Vriend G, Jacob-Hirsch J, Shaag A, et al. 2006. Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am J Hum Genet 79: 869-877.
108. Srivastava N, Prakash J, Lakhan R, Agarwal CG, Pant DC, Mittal B. 2010. A common polymorphism in the promoter of UCP2 is associated with obesity and hyperinsulenemia in northern Indians. Mol Cell Biochem 337: 293-298.
109. Stewart JB, Freyer C, Elson JL, Wredenberg A, Cansu Z, Trifunovic A, Larsson NG. 2008. Strong purifying selection in transmission of mammalian mitochondrial DNA. PLoS Biol 6: e10.
110. Torroni A, Petrozzi M, D'Urbano L, Sellitto D, Zeviani M, Carrara F, Carducci C, Leuzzi V, Carelli V, Barboni P, et al. 1997. Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet 60: 1107-1121.
111. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, Bruder CE, Bohlooly YM, Gidlof S, Oldfors A, Wibom R, et al. 2004. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417-423.
112. Trimmer PA, Bennett JP Jr. 2009. The cybrid model of sporadic Parkinson's disease. Exp Neurol 218: 320-325.
113. Tsukihara T, Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K, Nakashima R, Yaono R, Yoshikawa S. 1996. The whole structure of the 13-subunit oxidized cytochrome c oxidase at 2.8 A. Science 272: 1136-1144.
114. Tyynismaa H, Mjosund KP, Wanrooij S, Lappalainen I, Ylikallio E, Jalanko A, Spelbrink JN, Paetau A, Suomalainen A. 2005. Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice. Proc Natl Acad Sci 102: 17687-17692.
115. Udar N, Atilano SR, Memarzadeh M, Boyer DS, Chwa M, Lu S, Maguen B, Langberg J, Coskun P, Wallace DC, et al. 2009. Mitochondrial DNA haplogroups associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 50: 2966-2974.
116. van den Ouweland JM, Bruining GJ, Lindhout D, Wit JM, Veldhuyzen BF, Maassen JA. 1992. Mutations in mitochondrial tRNA genes: Non-linkage with syndromes of Wolfram and chronic progressive external ophthalmoplegia. Nucl Acids Res 20: 679-682.
117. van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, SmallGW, et al. 2004. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365: 28-32.
118. Wallace DC. 1992a. Diseases of the mitochondrial DNA. Annu Rev Biochem 61: 1175-1212.
119. Wallace DC. 1992b. Mitochondrial genetics: A paradigm for aging and degenerative diseases? Science 256: 628-632.
120. Wallace DC. 1994. MitochondrialDNAsequence variation in human evolution and disease. Proc Natl Acad Sci 91: 8739-8746.
121. Wallace DC. 2005. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu Rev Genet 39: 359-407.
122. Wallace DC. 2007. Why do we still have a maternally inherited mitochondrial DNA? Insights from evolutionary medicine. Annu Rev Biochem 76: 781-821.
123. Wallace DC. 2008. Mitochondria as chi. Genetics 179: 727-735.
124. Wallace DC. 2009. Mitochondria, bioenergetics, and the epigenome in eukaryotic and human evolution. Cold Spring Harb Symp Quant Biol 74: 383-393.
125. Wallace DC. 2010. Colloquium paper: Bioenergetics, the origins of complexity, and the ascent of man. Proc Natl Acad Sci 107 (suppl 2): 8947-8953.
126. Wallace DC, Fan W. 2010. Energetics, epigenetics, mitochondrial genetics. Mitochondrion 10: 12-31.
127. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJ, Nikoskelainen EK. 1988a. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242: 1427-1430.
128. Wallace DC, Zheng X, Lott MT, Shoffner JM, Hodge JA, Kelley RI, Epstein CM, Hopkins LC. 1988b. Familial mitochondrial encephalomyopathy (MERRF): Genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease. Cell 55: 601-610.
129. Wallace DC, Brown MD, Lott MT. 1999. Mitochondrial DNA variation in human evolution and disease. Gene 238: 211-230.
130. Wallace DC, Ruiz-Pesini E, Mishmar D. 2003. MtDNA variation, climatic adaptation, degenerative diseases, and longevity. Cold Spring Harb Symp Quant Biol 68: 479-486.
131. Wallace DC, Lott MT, Procaccio V. 2007. Mitochondrial genes in degenerative diseases, cancer and aging. In Emery and Rimoin's principles and practice of medical genetics, 5th ed. (ed. Rimoin DL et al.), pp. 194-298. Churchill Livingstone/ Elsevier, Philadelphia.
132. Wallace DC, Fan W, Procaccio V. 2010. Mitochondrial energetics and therapeutics. Annu Rev Pathol 5: 297-348.
133. Wang Y, Michikawa Y, Mallidis C, Bai Y, Woodhouse L, Yarasheski KE, Miller CA, Askanas V, Engel WK, Bhasin S, et al. 2001. Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc Natl Acad Sci 98: 4022-4027.
134. Watt IN, Montgomery MG, Runswick MJ, Leslie AG, Walker JE. 2010. Bioenergetic cost of making an adenosine triphosphate molecule in animal mitochondria. Proc Natl Acad Sci 107: 16823-16827.
135. Zeviani M, Bresolin N, Gellera C, Bordoni A, Pannacci M, Amati P, Moggio M, Servidei S, Scarlato G, DiDonato S. 1990. Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: A new autosomal dominant disease. Am J Hum Genet 47: 904-914.
136. Zhang J, Asin-Cayuela J, Fish J, Michikawa Y, Bonafe M, Olivieri F, Passarino G, DeBenedictis G, Franceschi C, Attardi G. 2003. Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes. Proc Natl Acad Sci 100: 1116-1121.
137. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, JungerW, Brohi K, Itagaki K, Hauser CJ. 2010. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107.
138. Zhu J, Chu CT. 2010. Mitochondrial dysfunction in Parkinson's disease. J Alzheimer's Dis 20 (suppl 2): S325-S334.
139. Ziviani E, Whitworth AJ. 2010. How could Parkin-mediated ubiquitination of mitofusin promote mitophagy? Autophagy 6: 660-662.